The Evolution of Schizophrenia: A Model for Selection by Infection, with a Focus on NAD

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|1|100-109

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.1, 2009-01, pp. : 100-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Schizophrenia in Children and Adolescents: Focus on Pharmacotherapy

By Masi Gabriele   Liboni Francesca  

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 179-208

Adis International

Access to resources Recommend Favorite

Reducing Suicide Risk in Schizophrenia: Focus on the Role of Clozapine

By Meltzer H.Y.  

CNS Drugs, Vol. 14, Iss. 5, 2000-11 ,pp. : 355-365

Adis International

Access to resources Recommend Favorite

Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis

By  

Current Pharmaceutical Design, Vol. 19, Iss. 20, 2013-06 ,pp. : 3689-3712

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

By Friedman Joseph  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite

First-Episode Schizophrenia: A Focus on Pharmacological Treatment and Safety Considerations

By Kelly Deanna L.   Conley Robert R.   Carpenter William T.  

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1113-1138

Adis International

Access to resources Recommend Favorite